Please join us for our next RDU NAACCR Talk!
February 26th, 2024, 2 pm: RDU NAACCR Talk--Topics in Pediatric Cancer
To register go to: https://education.naaccr.org/freewebinars
CE: N/A
Adolescent and Young Adult (AYA) Oncology: The insights gained from the Malignant Germ Cell International Consortium (MaGIC).
Dr. A. Lindsay Frazier, MD
One of the most common adolescent and young adult (AYA) cancers are the cell tumors (GCTs), however no significant change has happened to GCTs treatments protocols in the last decades. The Malignant Germ Cell International Consortium (MaGIC) brings together the world's leading experts in germ cell tumors (GCTs), from across the spectrum of cancer research, with the shared goal of developing more effective treatments for GCTs through scientific inquiry. As the lead of the Malignant Germ Cell Tumor International Consortium, Dr Lindsay will discuss AYA Oncology and share important lessons learned in the field of GCT research.
Forecasting for Accurate Procurement of Pediatric Chemotherapies.
Dr. Shrivastava, MD, MPH
Forecasting the cost and quantities of pediatric chemotherapies is an essential part of ensuring a reliable supply of essential medicines for the care of children with cancer. Dr. Shrivastava will describe the importance of access to accurate registry data and its relevance today amongst several critical drug shortages.
Angela Martin, ODS-C
Training Specialist/Project Coordinator
NAACCR, Inc.
Phone: 217-698-0800 ext. 9
Email: amartin@naaccr.org
Website:naaccr.org
Education and Training Website: education.naaccr.org